KDS2010

DRUG2 trials

Sponsors

NeuroBiogen Co., Ltd

Conditions

Alzheimer's DiseaseMild Cognitive Impairment (MCI)Mild DementiaObese PatientsObesityOverweight

Phase 2

Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients

RecruitingNCT07009171

NeuroBiogen Co., LtdObese Patients, Obesity, Overweight

Start: 2025-07-29End: 2027-06-30Target: 75Updated: 2026-06-24

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

RecruitingNCT07027072

NeuroBiogen Co., LtdAlzheimer's Disease, Mild Cognitive Impairment (MCI), Mild Dementia

Start: 2025-08-06End: 2027-12-31Target: 114Updated: 2026-06-22